Article
Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
Anticancer research - 1 May 2014
Krikelis Dimitrios, Skoura Evangelia, Kotoula Vassiliki, Rondogianni Phivi, Pianou Nikoletta, Samartzis Alexandros, Xanthakis Ioannis, Fountzilas George, Datseris Ioannis E
Abstract excerpt
BACKGROUND: Although Kirsten rat sarcoma (KRAS) gene mutational testing is essential for the optimal design of therapeutic strategies for colorectal cancer, it is not always feasible or reliable. In this retrospective study, we examined whether (18)F-Fluorodeoxyglucose positron-emission tomography/computed tomography ((18)F-FDG PET/CT) scans can serve as a surrogate examination for KRAS mutational testing....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
